Sialorrhea - Therapeutic drug options

Annals of Pharmacotherapy

Volumn 36, Issue 11, 2002, Pages 1785-1790

  Tscheng, Dorothy Z ^a  

^a Ontario Pharmacists' Association   (Canada)

Author keywords

Glycopyrrolate; Sialorrhea

Indexed keywords

AMITRIPTYLINE; BENZATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; GLYCOPYRRONIUM BROMIDE; HYOSCYAMINE; METOPROLOL; PLACEBO; PROPANTHELINE BROMIDE; PROPRANOLOL; RANITIDINE; SCOPOLAMINE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BEHAVIOR; BEHAVIOR THERAPY; BRONCHIECTASIS; CEREBRAL PALSY; CHRONIC BRONCHITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DROWSINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; FLUSHING; HEADACHE; HUMAN; HYPERACTIVITY; HYPERSALIVATION; INJECTION PAIN; IRRITABILITY; MASSETER MUSCLE; MYDRIASIS; PARKINSON DISEASE; PAROTID GLAND; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; QUADRIPLEGIA; QUALITY OF LIFE; RESTLESSNESS; SIDE EFFECT; TREATMENT INDICATION; URINE RETENTION; XEROSTOMIA;

EID: 0036840095     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C019     Document Type: Article

References (18)

1. Blasco PA, Stansbury JCK. Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med 1996;150:932-5.
2. Pal PK, Calne DB, Calne S, Tsui JKC. Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000;54:244-7.
3. Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M. Treatment of sialorrhea with glycopyrrolate - A double-blind, dose-ranging study. Arch Pediatr Adolesc Med 2000;154:1214-8.
4. Davydov L, Botts SR. Clozapine-induced hypersalivation. Ann Pharmacother 2000;34:662-5.
5. Heine RG, Catto-Smith AG, Reddihough DS. Effect of antireflux medication on salivary drooling in children with cerebral palsy. Dev Med Child Neurol 1996;38:1030-6.
6. Nunn JH. Drooling: Review of the literature and proposals for management. J Oral Rehabil 2000;27:735-43.
7. Camp-Bruno JA, Winsberg BG, Green-Parsons AR, Abrams JP. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol 1989;31: 309-19.
8. Bachrach SJ, Walter RS, Trzcinski K. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy. Clin Pediatr 1998;37:485-90.
9. Yagiela JA. Agents affecting salivation. In: Maxwell L, ed. ADA Guide to Dental Therapeutics. 2nd Ed. Chicago: American Dental Association, 2000:198.
10. Crysdale WS, Raveh E, McCann C, Roske L, Kotler A. Management of drooling in individuals with neurodisability: A surgical experience. Dev Med Child Neurol 2001;43:379-83.
11. Newall AR, Orser R, Hunt M. The control of oral secretions in bulbar ALS/MND. J Neurol Sci 1996; 139 (Suppl):43-4.
12. Bhatia KP, Munchau A, Brown P. Botulinum toxin is a useful treatment in excessive drooling in saliva (letter). J Neurol Neurosurg Psychiatry 1999;67:697.
13. Gillis MC, ed. Robinul product monograph. In: Compendium of Pharmaceuticals and Specialties. Toronto: Canadian Pharmacists Association, 1999:1578-9.
14. Drug Product Database. Health Canada [cited 2002 Jul 8]. Available from: URL:http://www.hc-sc.gc.ca/hpb/drugs-dpd/.
15. Stern LM. Preliminary study of glycopyrrolate in the management of drooling (abstract). J Paediatr Child Health 1997;33:52-4.
16. Glycopyrrolate drug evaluation. In: Hutchison TA, Shahan DR, eds. DRUGDEX System. Greenwood Village, CO: MICROMEDEX (volume 111, exp 3/2002).
17. Lewis DW, Fontana C, Mehallick LK, Everett Y. Transdermal scopolamine for reduction of drooling in developmentally delayed children. Dev Med Child Neurol 1994;36:484-6.
18. Brodtkorb E, Wyzocka-Bakowska MM, Lillevold PE, Sandvik L, Saunte C, Hestnes A. Transdermal scopolamine in drooling. J Ment Defic Res 1988;32(pt 3):233-7.